Form 6-K MorphoSys AG For: Jan 11

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 5/17/2022

1. CRM
2. SPY
3. HD
4. WMT
5. TTWO
6. TWTR
7. GLBE

January 11, 2022 10:08 AM EST
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________

FORM 6-K

REPORT OF A FOREIGN ISSUER
PURSUANT TO RULE 13A-16 OR 15D-16
OF THE SECURITIES EXCHANGE ACT OF 1934
For January 11, 2022

_______________Commission File Number 1-38455_______

MorphoSys AG

Semmelweisstrasse 7
82152 Planegg
Germany
(Address of principal executive offices)
______________________

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ☐ No ☒

If ‘‘Yes’’ is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):




Exhibits



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

    MORPHOSYS AG (Registrant)

Date: January 11, 2022    By:    /s/ i.A. Isabelle Degbegni    
        Name: Isabelle Degbegni
        Title:    Director Investor Relations
    

    By:    /s/ i.A. Kristina Grötsch    
        Name: Kristina Grötsch
        Title:    Coordinator Investor Relations    




Notification of managers`transactions according to article 19 MAR
Via Fax to BaFin (+49(0)228/4108-62963) and to the issuer

1
Details of the person discharging managerial responsibilities/person closely associated
a)NameC&F Consulting EURL
2
Reason for the notification
a)Position/statusPerson closely associated; relevant person discharging managerial responsibilities: Dr. Marc Cluzel, Chairman of the Supervisory Board of MorphoSys AG
b)Initial notification/AmendmentInitial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameMorphoSys AG
b)LEI529900493806K77LRE72
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument. type of instrument
Identification code
Shares of MorphoSys AG, ISIN DE0006632003
b)Nature of the transactionAcquisition
c)Price(s) and volume(s)Price(s)
 Volume(s)

30.73 €
46,088.85 €
d)Aggregated information
Aggregated volume


Price


46,088.85 €

30.73 €
e)Date of the transaction
2022-01-07; UTC+1
f)Place of the transactionXetra
image_0.jpg
(1)  Commission Delegated Regulation (EU) 2016/522 of 17 December 2015 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council as regards an exemption for certain third countries public bodies and central banks. the indicators of market manipulation. the


disclosure thresholds. the competent authority for notifications of delays. the permission for trading during closed periods and types of notifiable managers' transactions (see page 1 of this Official Journal).


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings